An experimental study in vivo and in vitro on the antitumor activity of trichostatin A visa hypoxia-inducible factor-2α

程冬冬,杨庆诚,张智长

DOI: https://doi.org/10.3969/j.issn.2095-252X.2013.02.007

2013-01-01

Abstract:Objective To investigate the antitumor mechanism of histone deacetylase (HDAC) inhibitor trichostatin A (TSA) via hypoxia-inducible factor-2α (HIF-2α). Methods Osteosarcoma MG-63 cells were cultured under the hypoxia condition in vitro, and then treated with TSA. The effects of TSA at different concentrations on the expression of HIF-2α, vascular endothelial growth factor (VEGF) messenger RNA (mRNA) and glucose transporter-1 (GLUT-1) mRNA were tested by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. MG-63 cells and von Hippel-Lindau (VHL) deficient 786-0 cells were treated by the proteasome inhibitor MG132, and the effects of TSA on the expression of HIF-2α were tested by western blotting. Osteosarcoma MG-63 cells were injected subcutaneously into nude mice. When tumors were about 20 mm3 in size, the mice were randomly divided into 2 groups: TSA group (N=6) and normal saline group (N=6). The mice were dosed each 3 days. The tumor tissue morphology was observed under the microscope 17 days later. After the mice were sacrificed, the protein was extracted from the tumor tissues, and the expression of HIF-2α was tested by western blotting. Results In cultured MG-63 cell lines, TSA inhibited the expression of HIF-2α, VEGF mRNA and Glut-1 mRNA in a concentration-dependent manner under the hypoxia condition in vitro; The proteasome inhibitor MG132 could reverse the inhibitory effects of TSA on HIF-2α. In VHL deficient 786-0 cell lines, TSA could also inhibit the HIF-2α expression in a concentration-dependent manner, and MG132 could reverse the effects. In animal xenografts, TSA inhibited the expression of HIF-2α. Conclusions The experiments show that TSA inhibits the HIF-2α expression by a VHL-independent but proteasome-dependent pathway, which suggests that the anticancer effects of TSA are partially mediated by its inhibition of HIF-2α. It provides new insights into the molecular mechanism of the antitumor effects of HDAC inhibitors.